2Lenz k, Hortnagl H, Draml W, et al Beneficial effects of 8 - ornithin vasopressin on renal dysfunction in decompensated cirrhosis[ J]. Gut , 1989,30(1):90-96.
3Acnz K, Hortnagl H , Druml W , et al . ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis , effects on renal hemodynamics and atrial natriuretic factor[ J]. Gastroenterology , 1991,101 ( 4 ) : 1060 - 1067.
4Hadengue A, Gadano A, Moreau R, et al. Beneficial effects of the 2 - day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome[ J ]. J Hepatol, 1998,29 ( 4 ) : 565 - 570.
5Soper CP, Latif AB, Bending MR . Amelioration of hepatorenal syndrome with selective endothelin - A antagonist [ Letter] [ J ]. Lancet, 1996,347: 1842 - 1843.
6Holt S, Goodier D, Marley R, et al. Improvement in renal function in hepatorenal syndrome with N - acetylcysteine [ J ]. Lancet, 1999, 353:294 - 295.
7Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment[J]. Hepatology ,2001,34(6): 1242 - 1251.
8Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [ J]. Hepatology, 1996,23 ( 1 ) : 164 - 176.
9Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired response to furosemide during prolonged therapy [ J ]. J Clin Invest , 1989, 83(1): 113 - 126.
10Gregory PB, Broelcelschen PH, Hill MD,et al. Complications of diuresis in the alcoholic patient with ascites : a controlled trial [ J ]. Gastroenterology, 1977,7 (3) : 534 - 538.
